National Cancer Control Institute. National cancer incidence 2012,Korea. Goyang:NationalCancerCenter; 2014.
MinKJ,LeeYJ,Suh M,YooCW,Lim MC,ChoiJ,et al.TheKorean guideline forcervicalcancerscreening.JGynecolOncol 2015;26:232-9.
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC,Wacholder S. Human papillomavirus and cervicalcancer.Lancet 2007;370:890-907.
Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M,et al. The 2001 Bethesda System:terminology forreporting results ofcervicalcytology.JAMA2002;287:2114-9.
Baer A, Kiviat NB, Kulasingam S, Mao C, Kuypers J, Koutsky LA. Liquidbased Papanicolaou smears without a transformation zone component:should cliniciansworry?ObstetGynecol 2002;99:1053-9.
ZhaoC,AustinRM.Adjunctive high-risk human papillomavirusDNAtesting is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample. Cancer 2008;114:242-8.
Park HK.Theimpact of introducing the Korean Medical Licensing Examination clinical skills assessment on medicaleducation.J Korean MedAssoc 2012;55:116-23.
Baker RM. Improving the adequacy of Pap smears.Am Fam Physician 1989;39:109-14.
Sandelowski M, Barroso J.Writing the proposal for a qualitative research methodology project.QualHealthRes 2003;13:781-820.
Sams SB, Currens HS, Raab SS. Liquid-based Papanicolaou tests in endometrial carcinoma diagnosis: performance,error root cause analysis, and quality improvement.AmJClin Pathol 2012;137:248-54.
Committee on Practice Bulletins?Gynecology.ACOG Practice Bulletin Number 131:screening forcervicalcancer.ObstetGynecol 2012;120:122238.
Whitlock EP,VescoKK,Eder M,Lin JS,SengerCA,Burda BU.Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.Ann Intern Med 2011;155:687-97,W214-5.
Lee KR,Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inhorn SL. Comparison of conventional Papanicolaou smears and a fluid-based,thinlayersystemforcervicalcancerscreening.ObstetGynecol 1997;90:278-84.
Vooijs PG,EliasA, van derGraafY,Veling S.Relationship between the diagnosis of epithelial abnormalities and the composition of cervical smears. ActaCytol 1985;29:323-8.
Martin-Hirsch P, Lilford R, Jarvis G, Kitchener HC. Efficacy of cervicalsmear collection devices: a systematic review and meta-analysis. Lancet 1999;354:1763-70.
Tacken MA, Braspenning JC, Mulder J,Hermens RP, NelenWL, de Bakker DH,et al.Lossto follow-up ofcervicalsmearswithoutendocervicalcolumnarcellsis not disturbing.EurJGynaecolOncol 2006;27:42-6
Saslow D, Solomon D, Lawson HW,Killackey M,Kulasingam SL,Cain J,et al.American Cancer Society,American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.Am J Clin Pathol 2012;137:516-42.
Massad LS,EinsteinMH,HuhWK,KatkiHA,KinneyWK,SchiffmanM,et al. 2012 updated consensus guidelines for the management of abnormal cervicalcancerscreening tests and cancer precursors.J LowGenit Tract Dis 2013;17(5 Suppl 1):S1-S27.
Fox R,NixAB, Fielder H.A comparison of variability in Papanicolaou and liquid-based cytology inadequacy rates using Shewhart control charts.Cytopathology 2006;17:175-81.
Buntinx F,Knottnerus JA,Crebolder HF, Seegers T, Essed GG, Schouten H. Does feedback improvethe quality of cervical smears?: a randomized controlled trial.BrJGen Pract 1993;43:194-8.
Sirovich BE,WelchHG.Cervicalcancerscreening amongwomenwithout a cervix.JAMA2004;291:2990-3.